INVITED
PRESENTATIONS:
1.
“Effect of Immunosuppressants Cyclosporine and Prednisolone on Drug
Disposition”, University of Georgia, School of Pharmacy, October 1986.
2.
“Effect of disease states - diabetes and arthritis, on the
pharmacokinetics and pharmacodynamics of cyclosporine in rats”.
University of Georgia, School of Pharmacy, October 1988.
3.
"Clinical Management of Transplant Patients". D’Souza, M.J.,
(Moderator and Speaker), Venkataramanan, R., and Solomon, H., Symposia, American
Pharmaceutical Association Meeting (APhA
Meeting), Atlanta, GA, March 1988.
4. “Use of
monoclonal antibody treatment in treatment of gram positive and gram negative
models of septic shock- evaluation of cytokine profiles”, D’Souza, M.J.,
(Main Speaker- Invited Speaker Symposium); Oliver, J. & Oettinger, C., Emory
University, School of Medicine, Atlanta, GA, April 1993
5.
“Tumors and Cytokines”. Tata Memorial Cancer Center, Bombay India,
December 1993.
6. “Use of
monoclonal antibody treatment in organ transplantation- study of cytokine
profiles”, D’Souza, M.J., (Main Speaker- Invited Speaker Symposium); Oliver,
J. & Oettinger, C., – Emory University, School of Medicine, Atlanta, GA,
September 1993
7.“The use
of microencapsulated monoclonal antibodies in septic shock and immunologic renal
disease”. D’Souza, M.J., & Oettinger, C., Georgia Biomedical Research
Partnership, Inc., Atlanta, GA, March 1994.
8.
“Targeting strategies using Macrophages and Microcapsules”. Mercer
University Board of Trustees Meeting. Mercer University, Macon, GA, April 1994
9. Cyclosporine - in autoimmune
diseases- arthritis, diabetes and psoriasis symposium)” Hematology Congress
Conference, Bombay, India, November/ December 1994
10. “Targeted strategies using
microcapsules and macrophages”. Glaxo Laboratories, Research Triangle, NC,
October 1994
11. “Targeted strategies using macrophages and
microencapsulated drugs”, (Inflammatory Cytokine Antagonists - Targets,
Strategies and Indications), Cambridge Health Institute Meeting, Philadelphia,PA,
October 1994
12.
“Site specific microencapsulated drug targeting strategies to the liver
and the gastrointestinal tract”. National
Institutes of Health, Bethesda, October 1995.
13. “Preparation, evaluation
and organ targeting of bioactive protein microspheres”. D’Souza, M.J., and
Oettinger, C., Anergen Pharmaceuticals, September 1997
14. “Gene
targeting of microencapsulated oligonucleotides”. D’Souza, M.J., and
Oettinger, C., AVI Bio Pharma, Corvallis, Oregon, September 1999
Return
to Dr. Martin D'Souza's Home Page